Kidney Research UK has welcomed a decision that will enable more people living with primary IgA nephropathy (IgAN) to access a targeted treatment on the NHS in England.
2 Likes
Kidney Research UK has welcomed a decision that will enable more people living with primary IgA nephropathy (IgAN) to access a targeted treatment on the NHS in England.